The induced decrease in TLR2 and TLR4 by cerebrolysin in the alcoholic liver of rats.

ALD TLR2 TLR4 cerebrolysin innate immunity

Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
Sep 2019
Historique:
revised: 13 12 2018
received: 21 11 2018
accepted: 18 12 2018
pubmed: 14 2 2019
medline: 14 2 2019
entrez: 14 2 2019
Statut: ppublish

Résumé

Toll-like receptors (TLRs) are innate immunity receptors, which have an important role in modulating inflammation in disease. Cerebrolysin is a biotechnologically prepared peptide that stimulates neurotrophic regulation in the central nervous system. The aim of the present study was to investigate the effect of experimenting cerebrolysin on TLR2 and TLR4 in alcoholic liver disease (ALD). TLR2 and TLR4 expressions were determined using real-time polymerase chain reaction in rats, which have used alcohol and they were separated into five groups. The results of the present study showed that in mild dose of cerebrolysin, the expression of TLR2 and TLR4 was decreased significantly than other groups. Also, the results of the western blot analysis proved the same. The present study demonstrated that the anti-inflammatory effect of cerebrolysin can decrease the TLR2 and TLR4 expressions through downregulating nuclear factor-κB pathway in the ALD disease.

Identifiants

pubmed: 30756376
doi: 10.1002/jcp.28293
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16290-16294

Subventions

Organisme : 1-Drug Applied Research Center (DARC),Tabriz University of Medical Sciences, Tabriz,Iran
ID : 91047403

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Javad Mahmoudi (J)

Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Ata Mahmoodpoor (A)

Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Mehdi Amirnia (M)

Department of Dermatology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Tohid Kazemi (T)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Pooneh Chokhachi Baradaran (P)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Shirin Sheikh Najafi (S)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Saeed Sadigh-Eteghad (S)

Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Fereshteh Farajdokht (F)

Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Huaxi Xu (H)

Department of Immunology, Jiangsu University of Medical Sciences, Zhenjiang, China.

Mobina Belalzadeh (M)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Siamak Sandoghchian Shotorbani (S)

Drug Applied Research Center (DARC), Tabriz University of Medical Sciences, Tabriz, Iran.

Classifications MeSH